Sort
30,917 grants matching “tumor microenvironment”
Angiogenesis and Tumor Growth
$592,321Giovanna Tosato · Division Of Clinical Sciences - Nci · ZIA · FY2009 · CA
Quantitative In Vivo 68Ga-Fibroblast-Activation-Protein-Inhibitors (FAPI)-46 PET Imaging of Cancer-Associated Fibroblasts (CAFs) in Pancreatic Ductal Adenocarcinoma (PDA)
$592,291Ajit Harishkumar Goenka · Mayo Clinic Rochester · R01 · FY2023 · CA
The Role of TIMPs in Cell Growth, Tumor Progression and Metastasis
$592,289William Stetler-Stevenson · Division Of Clinical Sciences - Nci · ZIA · FY2023 · CA
RP-3: Elucidating Mechanisms of Sensitivity and Resistance to Checkpoint Blockade Therapy for Rational Multi-Drug Immunotherapy in Urothelial Cancers
$592,269Jonathan Eric Rosenberg · Sloan-Kettering Inst Can Research · P50 · FY2021 · CA
Bioprinting Plant Virus Nanoparticles for Immunotherapy and Relapse Prevention of Ovarian Cancer
$592,114Nicole Franziska Steinmetz · University Of California, San Diego · R01 · FY2020 · CA
Streptococcus species as potential therapeutics for oropharyngeal squamous cell carcinoma
$592,080Stephanie Dorta-Estremera · University Of Puerto Rico Med Sciences · R16 · FY2025 · DE
Identifying Metabolic Dependencies of Pancreatic Cancers
$592,013Alec Kimmelman · New York University School Of Medicine · R35 · FY2018 · CA
Novel CCR2 PET for Pancreatic Cancer Imaging and Prediction of Response to Standard and CCR2-Targeted Therapy
$591,868Farrokh Dehdashti · Washington University · R01 · FY2022 · CA
Targeting the Immune System in Mouse Models of Lung Adenocarcinoma
$591,863Katerina Abigail Politi · Yale University · R01 · FY2016 · CA
Rapid motion-robust quantitative DCE-MRI for the assessment of gynecologic cancers
$591,847Ricardo Otazo · Sloan-Kettering Inst Can Research · R01 · FY2022 · CA
Serial immunotherapy combination to modulate the tumor environment in patients with metastatic gastroesophageal cancer
$591,765Harry H Yoon · Mayo Clinic Rochester · R01 · FY2024 · CA
Regulators of Cancer Immunotherapy Response
$591,752Kai W Wucherpfennig · Dana-Farber Cancer Inst · R01 · FY2020 · CA
HTS Assays for Targeting the cGAS-STING Pathway in Autoimmune Diseases and Cancer
$591,712Robert G Lowery · Bellbrook Labs, Llc · R44 · FY2018 · GM
Non-neoplastic cell types dictate gliomagenesis and
$591,607Dolores Hambardzumyan · Emory University · U01 · FY2015 · CA
The role of lymph node structural organization in naïve T cell decline with age
$591,539Jessica N Lancaster · Mayo Clinic Arizona · R01 · FY2023 · AG
The role of lymph node structural organization in naïve T cell decline with age
$591,539Jessica N Lancaster · Mayo Clinic Arizona · R01 · FY2024 · AG
Translating Autoantibodies Into Chimeric Antigen Receptor-T cell Therapy for Small Cell Lung Cancer
$591,527Kristin J Lastwika · Fred Hutchinson Cancer Center · U01 · FY2023 · CA
Non-neoplastic cell types dictate gliomagenesis and
$591,519Dolores Hambardzumyan · Cleveland Clinic Lerner Com-Cwru · U01 · FY2012 · CA
DECODING THE TUMOR MICROENVIRONMENT REMODELING OF CANCER VACCINE TREATMENT IN PLEURAL MESOTHELIOMA
$591,500Icahn School Of Medicine At Mount Sinai · · FY2025 · Defense Health Agency
Homologous recombination deficiency and beyond in pancreatic cancer: evaluating the regulators of response to pembrolizumab and olaparib (POLAR) from the immune and genomic perspectives
$591,430Eileen Mary O'Reilly · Sloan-Kettering Inst Can Research · P50 · FY2025 · CA
Transcriptional Regulation in ZFTA-RELA Ependymoma
$591,375Stephen C Mack · St. Jude Children'S Research Hospital · R01 · FY2024 · CA
Training Program in Basic Cancer Research
$591,366Maureen E Murphy · Wistar Institute · T32 · FY2017 · CA
Modulation of the tumor microenvironment with probiotic therapies
$591,316Tal Danino · Columbia Univ New York Morningside · R01 · FY2020 · CA
Combating melanoma with an attenuated bacterial therapeutic
$591,249Jianxun Jim Song · Texas A&M University Health Science Ctr · R01 · FY2024 · CA
Investigating GLI transcription factors as regulators of the pancreatic cancer microenvironment
$591,242Benjamin Allen · University Of Michigan At Ann Arbor · R01 · FY2023 · CA